Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

LASIK satisfaction study launches: will new tech deliver clearer vision?

NCT ID NCT07084844

Symptom relief Sponsor: Mann Eye Institute Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tracks how satisfied 52 people with nearsightedness and astigmatism are after getting Wavelight Plus LASIK, a personalized laser eye surgery. Researchers will measure vision quality, daily life impact, and any visual symptoms like glare or halos for up to 3 months after surgery. The goal is to see if this advanced laser system improves patient happiness and quality of vision.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Wavelight Plus LASIK (laser eye surgery device)
What this could lead to
If successful, this could confirm that Wavelight Plus LASIK provides high patient satisfaction and improved quality of life for nearsighted people with astigmatism.
What could go wrong
This is a small, single-site observational study with no comparison group. Results may not apply to all patients, and long-term outcomes beyond 3 months are not assessed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 52 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Eligible test subjects will be 18 to 39 years of age and who are candidates for Wavelight Plus LASIK to correct myopia or myopic astigmatism.

Ages

18 to 39 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Between the ages of 18 and 39 * Meet the standard care requirements for LASIK * Spherical equivalent (SE) more than -1.00D and up to -9.00 diopters * Myopia ≤ -8.00 sphere (in minus cylinder format) and up to -3.00D astigmatism * SE difference between the manifest refraction and the Sightmap measured SE being less than 0.75D * Minimum residual stromal bed thickness of 250 µm * If currently wearing contact lenses: * Soft CTL wearers discontinue for minimum 3 days * RGP CTL wearers discontinue for 1 month per decade of wear * Stable refraction (2 consecutive manifest refractions within 0.25 SE) * Stable K readings (2 consecutive K readings in 2 consecutive visits) * Willing and able to complete all post-operative visits * Pre-surgery BCDVA of 20/20 (0.00 logMAR) or better in each eye.Mesopic pupil size ≥ 4.5mm Exclusion Criteria: * Subjects with any prior ocular surgery * Subjects with topographic evidence of keratoconus, or ectasia * Subjects with autoimmune diseases * Subjects who are pregnant or nursing * Systemic disease likely to affect wound healing, such as diabetes and severe atopy * Any ocular disease (including un-controlled dry eye) which in the investigator's opinion would affect the outcome of refractive surgery

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Astigmatism are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

astigmatism myopia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Astigmatism Myopia

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Mann Eye Institute

    RECRUITING

    Houston, Texas, 77004, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.